͵͵

News

A microbiologist explains what’s known about this smallpox cousin

Rodney E. Rohde
By Rodney E. Rohde
Aug. 17, 2024

On Aug. 14, the World Health Organization declared mpox a . There have been over 15,600 cases and over 530 deaths reported in the Democratic Republic of the Congo and neighboring countries in Africa. The disease had previously caused a global outbreak from 2022 to 2023.

Mpox – previously called monkeypox – isn’t a new disease. The , when the virus was isolated from a child suspected of having smallpox in the Democratic Republic of Congo (DRC). Though usually mild, mpox can still potentially cause severe illness. Health officials are concerned that more cases will arise with increased travel.

Mpox causes lesions that resemble pus-filled blisters, which eventually scab over.
Mpox causes lesions that resemble pus-filled blisters, which eventually scab over.

I’m who has worked in for over three decades, especially in the realm of diseases with animal origins. What exactly is happening in the current outbreak, and what does history tell us about mpox?

A cousin of smallpox

is caused by the monkeypox virus, which belongs to a subset of the Poxviridae family of viruses called Orthopoxvirus. This subset includes the smallpox, and cowpox viruses. While an , African rodents are suspected to play a part in transmission. The monkeypox virus has only been isolated twice from an animal in nature. is currently only available at Laboratory Response Network labs in the U.S. and globally.

The name “monkeypox” comes from the of the illness in animals in 1958, when two outbreaks occurred in monkeys kept for research. However, from monkeys to humans, nor are monkeys major carriers of the disease.

The virus that causes mpox belongs to the Poxviridae family of viruses, which includes smallpox.
The virus that causes mpox belongs to the Poxviridae family of viruses, which includes smallpox.

Epidemiology

Since the first reported human case, mpox has been found in , with the majority of infections in the DRC. Cases outside of Africa have been linked to international travel or imported animals, including in the U.S. .

The was in 2003, from an outbreak in Texas linked to a shipment of animals from Ghana. There were also travel-associated cases in in Maryland. The outbreak of mpox that began .

Because mpox is closely related to smallpox, the smallpox vaccine can against infection from both viruses. Since smallpox was officially eradicated, however, for the U.S. general population were stopped in 1972. Because of this, mpox has been in unvaccinated people.

Transmission

The virus can be through contact with an infected person or animal or contaminated surfaces. Typically, the virus enters the body through broken skin, inhalation or the mucous membranes in the eyes, nose or mouth. Researchers believe that human-to-human transmission is mostly through inhalation of large respiratory droplets rather than direct contact with bodily fluids or indirect contact through clothes.

are worried that the virus may currently be spreading undetected through community transmission, possibly through a new mechanism or route. Where and how infections are occurring are still under investigation.

Signs and symptoms

After the virus enters the body, it starts to through the body via the bloodstream. Symptoms usually don’t appear until one to two weeks after infection.

, but are usually milder than those of smallpox. Flu-like symptoms are common initially, ranging from fever and headache to shortness of breath. One to 10 days later, a rash can appear on the extremities, head or torso that eventually turns into blisters filled with pus. Overall, symptoms usually last two to four weeks, while skin lesions usually scab over in 14 to 21 days.

While mpox is rare and usually nonfatal, of the disease kills . The form of the virus currently circulating is thought to be milder, with a fatality rate of less than 1%.

Vaccines and treatments

is primarily focused on relieving symptoms. According to the Centers for Disease Control and Prevention, no treatments are available to cure mpox infection.

Because smallpox is closely related to mpox, the smallpox vaccine can protect against both diseases.

Evidence suggests that the smallpox vaccine can help prevent mpox infections and decrease the severity of the symptoms. One vaccine known as is licensed in the U.S. to prevent mpox and smallpox.

Vaccination after exposure to the virus may also help decrease chances of severe illness. The CDC currently recommends smallpox vaccination only in people who have been or are likely to be exposed to mpox. are at high risk.

This is an updated version of originally published on May 20, 2022.

This article is republished from under a Creative Commons license. Read the .

The Conversation

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Rodney E. Rohde
Rodney E. Rohde

Rodney E. Rohde is a professor of clinical laboratory science at Texas State University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.